CDKN2A PVs were frequent in patients with a family history of PC (8/55, 14.5%) and with a personal or family history of melanoma (6/30, 20%); however, the rate remains high (8/283, 2.8%) in sporadic subjects. Here, CDKN2A is linked to melanoma.